Sauye-sauyen Halittar Dan Adam ta EGFR 29
Sunan samfurin
Kayan Gano Canje-canje na Halittar Halittar HWTS-TM0012A-Human EGFR 29 (Fluorescence PCR)
Ilimin Cututtuka
Ciwon daji na huhu ya zama babban abin da ke haifar da mace-macen ciwon daji a duk duniya, wanda hakan ke barazana ga lafiyar ɗan adam. Ciwon daji na huhu wanda ba ƙaramin ƙwayar halitta ba ne ke da alhakin kusan kashi 80% na marasa lafiya da ke fama da ciwon daji na huhu. EGFR a halin yanzu shine mafi mahimmancin abin da ake nufi da maganin ciwon daji na huhu wanda ba ƙaramin ƙwayar halitta ba ne. Phosphorylation na EGFR na iya haɓaka haɓakar ƙwayoyin cuta, bambance-bambance, mamayewa, metastasis, anti-apoptosis, da haɓaka angiogenesis na ƙari. Masu hana EGFR tyrosine kinase (TKI) na iya toshe hanyar siginar EGFR ta hanyar hana haɓakar EGFR autophosphorylation, ta haka yana hana yaduwa da bambance-bambancen ƙwayoyin cuta, haɓaka apoptosis na ƙwayoyin cuta, rage angiogenesis na ƙari, da sauransu, don cimma maganin da aka yi niyya ga ƙari. Yawancin bincike sun nuna cewa ingancin maganin EGFR-TKI yana da alaƙa da matsayin maye gurbin kwayar halittar EGFR, kuma yana iya hana haɓakar ƙwayoyin cuta tare da maye gurbin kwayar halittar EGFR. Kwayar halittar EGFR tana kan ɗan gajeren hannun chromosome 7 (7p12), tare da cikakken tsawon 200Kb kuma ta ƙunshi exons 28. Yankin da aka canza yana da yawa a cikin exons 18 zuwa 21, maye gurbin share codons 746 zuwa 753 akan exon 19 yana da kusan kashi 45% kuma maye gurbin L858R akan exon 21 yana da kusan kashi 40% zuwa 45%. Jagororin NCCN don Gano da Maganin Ciwon Huhu Mara Ƙaramin Kwayar Halitta ya bayyana a sarari cewa ana buƙatar gwajin maye gurbin kwayar halittar EGFR kafin a fara amfani da EGFR-TKI. Ana amfani da wannan kayan gwajin don jagorantar gudanar da magungunan epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), kuma yana samar da tushen magani na musamman ga marasa lafiya da ciwon huhu mara ƙaramin ƙwayar halitta. Ana amfani da wannan kayan aikin ne kawai don gano maye gurbi gama gari a cikin kwayar halittar EGFR a cikin marasa lafiya da ciwon huhu mara ƙaramin ƙwayar halitta. Sakamakon gwajin don amfani ne kawai na asibiti kuma bai kamata a yi amfani da shi azaman tushen magani na musamman ga marasa lafiya ba. Ya kamata likitocin asibiti su yi la'akari da yanayin majiyyaci, alamun magani, da magani. Ana amfani da martani da sauran alamun gwajin dakin gwaje-gwaje da sauran abubuwan don yin hukunci dalla-dalla kan sakamakon gwajin.
Tashar
| FAM | Buffer na IC Reaction, Buffer na L858R Reaction, Buffer na 19del Reaction, Buffer na T790M Reaction, Buffer na G719X Reaction, Buffer na 3Ins20 Reaction, Buffer na L861Q Reaction, Buffer na S768I Reaction |
Sigogi na Fasaha
| Ajiya | Ruwa: ≤-18℃ Cikin duhu; An yi shi da Lyophilized: ≤30℃ Cikin duhu |
| Tsawon lokacin shiryawa | Ruwa: Watanni 9; An yi shi da Lyophilized: Watanni 12 |
| Nau'in Samfuri | sabbin ƙwayoyin ciwon daji, sashen cututtuka da aka daskare, nama ko sashe na pathological da aka saka a cikin paraffin, plasma ko serum |
| CV | <5.0% |
| LoD | Gano maganin amsawar nucleic acid a ƙarƙashin asalin nau'in 3ng/μL na daji, zai iya gano ƙimar maye gurbi 1% cikin kwanciyar hankali |
| Takamaiman Bayani | Babu wani haɗin gwiwa-reactivity tare da DNA na kwayoyin halittar ɗan adam na daji da sauran nau'ikan maye gurbi |
| Kayan Aiki Masu Amfani | Tsarin PCR na Zamani na Aiyuka 7500Tsarin PCR na Zamani na Aiyuka 7300 Tsarin PCR na Ainihin Lokaci 5 na QuantStudio® Tsarin PCR na LightCycler® 480 na Ainihin Lokaci Tsarin PCR na BioRad CFX96 na Ainihin Lokaci |












